| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10967400 | Vaccine | 2013 | 10 Pages |
Abstract
We demonstrate in a murine model of chronic BP respiratory allergy the efficacy of SLIT with vectorized rBet v 1a. Thus, combining recombinant allergens with mucoadhesive vector systems paves the ground for improved second generation sublingual allergy vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sophie Tourdot, Sabi Airouche, Nathalie Berjont, Hélène Moussu, Didier Betbeder, Emmanuel Nony, Véronique Bordas-Le Floch, Véronique Baron-Bodo, Laurent Mascarell, Philippe Moingeon,